Mind Medicine (MindMed) Inc.·4

Mar 18, 4:45 PM ET

Wiley Matthew T. 4

4 · Mind Medicine (MindMed) Inc. · Filed Mar 18, 2025

Insider Transaction Report

Form 4
Period: 2025-03-17
Wiley Matthew T.
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-17+350,000350,000 total
    Exercise: $6.35Exp: 2035-03-16Common Shares (350,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option shall vest and become exercisable over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date

Documents

1 file
  • 4
    ownership.xmlPrimary

    4